17,520 resources
By Version
By Realm
Start Prev Rows 10600 - 10800 Next
Package | Version | Identity | Name/Title | Status | FMM | WG | Date | Realm | Source(s) |
---|---|---|---|---|---|---|---|---|---|
hl7.terminology | R5 | v3-IntracardiacRoute | IntracardiacRoute | active | 2014-03 | uv | tho | ||
hl7.terminology | R5 | v3-IntracartilaginousRoute | IntracartilaginousRoute | active | 2014-03 | uv | tho | ||
hl7.terminology | R5 | v3-IntracaudalRoute | IntracaudalRoute | active | 2014-03 | uv | tho | ||
hl7.terminology | R5 | v3-IntracavernosalRoute | IntracavernosalRoute | active | 2014-03 | uv | tho | ||
hl7.terminology | R5 | v3-IntracavitaryRoute | IntracavitaryRoute | active | 2014-03 | uv | tho | ||
hl7.terminology | R5 | v3-IntracerebralRoute | IntracerebralRoute | active | 2014-03 | uv | tho | ||
hl7.terminology | R5 | v3-IntracervicalRoute | IntracervicalRoute | active | 2014-03 | uv | tho | ||
hl7.terminology | R5 | v3-IntracisternalRoute | IntracisternalRoute | active | 2014-03 | uv | tho | ||
hl7.terminology | R5 | v3-IntracornealRoute | IntracornealRoute | active | 2014-03 | uv | tho | ||
hl7.terminology | R5 | v3-IntracoronalRoute | IntracoronalRoute | active | 2014-03 | uv | tho | ||
hl7.terminology | R5 | v3-IntracoronaryRoute | IntracoronaryRoute | active | 2014-03 | uv | tho | ||
hl7.terminology | R5 | v3-IntracorpusCavernosumRoute | IntracorpusCavernosumRoute | active | 2014-03 | uv | tho | ||
hl7.terminology | R5 | v3-IntradermalRoute | IntradermalRoute | active | 2014-03 | uv | tho | ||
hl7.terminology | R5 | v3-IntradiscalRoute | IntradiscalRoute | active | 2014-03 | uv | tho | ||
hl7.terminology | R5 | v3-IntraductalRoute | IntraductalRoute | active | 2014-03 | uv | tho | ||
hl7.terminology | R5 | v3-IntraduodenalRoute | IntraduodenalRoute | active | 2014-03 | uv | tho | ||
hl7.terminology | R5 | v3-IntraduralRoute | IntraduralRoute | active | 2014-03 | uv | tho | ||
hl7.terminology | R5 | v3-IntraepidermalRoute | IntraepidermalRoute | active | 2014-03 | uv | tho | ||
hl7.terminology | R5 | v3-IntraepithelialRoute | IntraepithelialRoute | active | 2014-03 | uv | tho | ||
hl7.terminology | R5 | v3-IntraesophagealRoute | IntraesophagealRoute | active | 2014-03 | uv | tho | ||
hl7.terminology | R5 | v3-IntragastricRoute | IntragastricRoute | active | 2014-03 | uv | tho | ||
hl7.terminology | R5 | v3-IntrailealRoute | IntrailealRoute | active | 2014-03 | uv | tho | ||
hl7.terminology | R5 | v3-IntralesionalRoute | IntralesionalRoute | active | 2014-03 | uv | tho | ||
hl7.terminology | R5 | v3-IntraluminalRoute | IntraluminalRoute | active | 2014-03 | uv | tho | ||
hl7.terminology | R5 | v3-IntralymphaticRoute | IntralymphaticRoute | active | 2014-03 | uv | tho | ||
hl7.terminology | R5 | v3-IntramedullaryRoute | IntramedullaryRoute | active | 2014-03 | uv | tho | ||
hl7.terminology | R5 | v3-IntramuscularRoute | IntramuscularRoute | active | 2014-03 | uv | tho | ||
hl7.terminology | R5 | v3-IntraocularRoute | IntraocularRoute | active | 2014-03 | uv | tho | ||
hl7.terminology | R5 | v3-IntraosseousRoute | IntraosseousRoute | active | 2014-03 | uv | tho | ||
hl7.terminology | R5 | v3-IntraovarianRoute | IntraovarianRoute | active | 2014-03 | uv | tho | ||
hl7.terminology | R5 | v3-IntrapericardialRoute | IntrapericardialRoute | active | 2014-03 | uv | tho | ||
hl7.terminology | R5 | v3-IntraperitonealRoute | IntraperitonealRoute | active | 2014-03 | uv | tho | ||
hl7.terminology | R5 | v3-IntrapleuralRoute | IntrapleuralRoute | active | 2014-03 | uv | tho | ||
hl7.terminology | R5 | v3-IntraprostaticRoute | IntraprostaticRoute | active | 2014-03 | uv | tho | ||
hl7.terminology | R5 | v3-IntrapulmonaryRoute | IntrapulmonaryRoute | active | 2014-03 | uv | tho | ||
hl7.terminology | R5 | v3-IntrasinalRoute | IntrasinalRoute | active | 2014-03 | uv | tho | ||
hl7.terminology | R5 | v3-IntraspinalRoute | IntraspinalRoute | active | 2014-03 | uv | tho | ||
hl7.terminology | R5 | v3-IntrasternalRoute | IntrasternalRoute | active | 2014-03 | uv | tho | ||
hl7.terminology | R5 | v3-IntrasynovialRoute | IntrasynovialRoute | active | 2014-03 | uv | tho | ||
hl7.terminology | R5 | v3-IntratendinousRoute | IntratendinousRoute | active | 2014-03 | uv | tho | ||
hl7.terminology | R5 | v3-IntratesticularRoute | IntratesticularRoute | active | 2014-03 | uv | tho | ||
hl7.terminology | R5 | v3-IntrathecalRoute | IntrathecalRoute | active | 2014-03 | uv | tho | ||
hl7.terminology | R5 | v3-IntrathoracicRoute | IntrathoracicRoute | active | 2014-03 | uv | tho | ||
hl7.terminology | R5 | v3-IntratrachealRoute | IntratrachealRoute | active | 2014-03 | uv | tho | ||
hl7.terminology | R5 | v3-IntratubularRoute | IntratubularRoute | active | 2014-03 | uv | tho | ||
hl7.terminology | R5 | v3-IntratumorRoute | IntratumorRoute | active | 2014-03 | uv | tho | ||
hl7.terminology | R5 | v3-IntratympanicRoute | IntratympanicRoute | active | 2014-03 | uv | tho | ||
hl7.terminology | R5 | v3-IntrauterineRoute | IntrauterineRoute | active | 2014-03 | uv | tho | ||
hl7.terminology | R5 | v3-IntravascularRoute | IntravascularRoute | active | 2014-03 | uv | tho | ||
hl7.terminology | R5 | v3-IntravenousRoute | IntravenousRoute | active | 2014-03 | uv | tho | ||
hl7.terminology | R5 | v3-IntraventricularRoute | IntraventricularRoute | active | 2014-03 | uv | tho | ||
hl7.terminology | R5 | v3-IntravesicleRoute | IntravesicleRoute | active | 2014-03 | uv | tho | ||
hl7.terminology | R5 | v3-IntravitrealRoute | IntravitrealRoute | active | 2014-03 | uv | tho | ||
hl7.terminology | R5 | v3-IontophoresisRoute | IontophoresisRoute | active | 2014-03 | uv | tho | ||
hl7.terminology | R5 | v3-Irrigation | Irrigation | active | 2014-03 | uv | tho | ||
hl7.terminology | R5 | v3-UrinaryBladderIrrigation | UrinaryBladderIrrigation | active | 2014-03 | uv | tho | ||
fhir.org.nz.ig.base | R4 | nz-residency | NZ Residency status | active | 2025-06 | us | |||
hl7.fhir.us.codex-radiation-therapy | R4 | codexrt-radiotherapy-isotope-vs | Radiotherapy Isotope Value Set | active | cgp | 2025-02 | us | sct | |
de.netzwerk-universitaetsmedizin.ebm-cpg | R5 | vs-rating-resources | Rating Resources | draft | 2022-09 | uv | internal | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1221.189 | Infertility, Male | active | 2024-04 | us | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1221.190 | Infertility, Male | active | 2024-04 | us | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1221.191 | Infertility, Male | active | 2024-04 | us | vsac | ||
hl7.eu.fhir.idea4rc | R4 | site-qualifier-i4rc | Body site qualifier | active | 2025-07 | eu | |||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1222.1446 | Covid Toes (Toes and/or Fingers) | active | 2024-06 | us | sct | ||
hl7.eu.fhir.idea4rc | R4 | treatment-technique-i4rc | Treatment Technique | active | 2025-07 | eu | |||
openehr.base | R5 | item-lifecyclestate | Item Lifecycle State ValueSet | informative | 3 | fhir | 2024-08 | uv | |
openehr.base | R5 | item-proportiontype | Item ProportionType ValueSet | informative | 3 | fhir | 2024-08 | uv | |
openehr.base | R5 | item-rmtype | Item rmType ValueSet | informative | 3 | fhir | 2024-08 | uv | |
hl7.terminology | R5 | v3-ActRelationshipItemsLocated | ActRelationshipItemsLocated | active | 2014-03 | uv | tho | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.193 | relatedconditions_COPD I10 | active | 2023-03 | us | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.173 | Asthma I10 | active | 2025-05 | us | icd | ||
hl7.terminology | R5 | v3-JejunumRoute | JejunumRoute | active | 2014-03 | uv | tho | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1032.102 | Suicide Attempt | active | 2024-06 | us | vsac | ||
nictiz.fhir.nl.stu3.zib2017 | R3 | 2.16.840.1.113883.2.4.3.11.60.40.2.14.3.2--20171231000000 | JuridischeStatusCodelijst | active | nl | oid | |||
hl7.fhir.au.base | R4 | au-jurisdiction-extended | Jurisdiction ValueSet - AU Extended | trial-use | 1 | 2025-06 | au | tho | |
phis.ig.createtest | R4 | krcore-edi-medication-codes | KR Core EDI Medication Codes | draft | 2021-11 | ||||
phis.ig.createtest | R4 | krcore-edi-procedure-codes | KR Core EDI Procedure Codes | draft | 2021-11 | ||||
phis.ig.createtest | R4 | krcore-edi-material-codes | KR Core EDI Material Codes | active | 2023-06 | ||||
phis.ig.createtest | R4 | krcore-kcd8-codes | KR Core KCD8 Codes | active | 2023-06 | ||||
phis.ig.createtest | R4 | krcore-korea-drug-codes | KR Core Korea Drug Codes | active | 2023-06 | ||||
phis.ig.createtest | R4 | krcore-insurance-types-codes | KR Core Insurance Types Codes | active | 2023-06 | ||||
phis.ig.createtest | R4 | krcore-vcnt-type-codes | KR Core Vaccination Type Codes | active | 2023-06 | ||||
phis.ig.createtest | R4 | krcore-healthcare-organization-type-codes | KR Core Organization Type Codes | active | 2023-06 | ||||
phis.ig.createtest | R4 | krcore-medicaldepartment-codes | KR Core Medical Department Codes | active | 2023-06 | ||||
phis.ig.createtest | R4 | krcore-condition-category-codes | KR Core Condition Category Codes | active | 2023-06 | tho | |||
phis.ig.createtest | R4 | krcore-doctor-qualification-codes | KR Core Doctor Qualification Codes | active | 2023-06 | ||||
phis.ig.createtest | R4 | krcore-vital-signs-codes | KR Core Vital Signs Codes | active | 2023-06 | loinc | |||
basisprofil.de | R3 | ValueSet-kbv-s-kbv-kv | kbv-s-kbv-kv | draft | 2017-10 | ||||
nictiz.fhir.nl.r4.zib2020 | R4 | 2.16.840.1.113883.2.4.3.11.60.40.2.12.12.2--20200901000000 | Kalmte_AgitatieCodelijst | active | nl | oid | |||
nictiz.fhir.nl.stu3.zib2017 | R3 | 2.16.840.1.113883.2.4.3.11.60.40.2.12.12.2--20171231000000 | Kalmte_AgitatieCodelijst | active | nl | oid | |||
hl7.fhir.uv.ichom-breast-cancer | R4 | InvolvedMarginsReoperationTypeVS | Re-operation due to involved margins ValueSet | trial-use | 2 | 2023-08 | uv | fhir sct tho | |
de.basisprofil.r4 | R4 | ArgeIkKlassifikationVS | ArgeIkKlassifikation ValueSet | active | 2025-06 | ||||
nictiz.fhir.nl.stu3.zib2017 | R3 | 2.16.840.1.113883.2.4.3.11.60.40.2.12.1.1--20171231000000 | KledingCodelijst | active | nl | oid | |||
de.basisprofil.r4 | R4 | kontaktart-de | KontaktartDe ValueSet | active | 2025-06 | ||||
de.basisprofil.r4 | R4 | kontaktebene-de | KontaktebeneDe ValueSet | active | 2025-06 | ||||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1248.94 | Oxygen Partial Pressure in Arterial Blood | active | 2024-01 | us | loinc | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1248.95 | Carbon Dioxide Partial Pressure in Arterial Blood | active | 2024-01 | us | loinc | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1248.96 | Arterial Blood pH | active | 2024-01 | us | loinc | ||
nictiz.fhir.nl.r4.zib2020 | R4 | 2.16.840.1.113883.2.4.3.11.60.40.2.13.1.5--20200901000000 | OnderzoekCodelijst | active | nl | loinc | |||
nictiz.fhir.nl.stu3.zib2017 | R3 | 2.16.840.1.113883.2.4.3.11.60.40.2.13.1.5--20171231000000 | OnderzoekCodelijst | active | nl | loinc | |||
nictiz.fhir.nl.stu3.zib2017 | R3 | 2.16.840.1.113883.2.4.3.11.60.40.2.13.1.3--20171231000000 | TestCodeCodelijst | active | nl | loinc | |||
hl7.fhir.us.ccda | R4 | 1.3.6.1.4.1.12009.10.2.5 | LOINC Imaging Document Codes | trial-use | cgp | 2022-07 | us | loinc | |
hl7.fhir.us.ccda | R4 | 2.16.840.1.113883.11.20.6.1 | ProcedureNoteDocumentTypeCodes | trial-use | cgp | 2018-05 | us | loinc | |
hl7.fhir.us.ccda | R4 | 2.16.840.1.113883.11.20.8.1 | ProgressNoteDocumentTypeCode | trial-use | cgp | 2018-05 | us | loinc | |
hl7.fhir.us.pacio-adi | R4 | LOINCPOLSTCPRAnswerList | LOINC POLST CPR Answer List | trial-use | 2 | pe | 2025-07 | us | loinc |
hl7.fhir.us.pacio-adi | R4 | LOINCPOLSTInitialTxAnswerList | LOINC POLST Initial Tx Answer List | trial-use | 2 | pe | 2025-07 | us | loinc |
hl7.fhir.us.pacio-adi | R4 | LOINCPOLSTMedAssistNutrAnswerList | LOINC POLST Med assist nutr Answer List | trial-use | 2 | pe | 2025-07 | us | loinc |
hl7.fhir.us.pacio-adi | R4 | LOINCPOLSTDiscussPartAnswerList | LOINC POLST discuss part List | trial-use | 2 | pe | 2025-07 | us | loinc |
hl7.fhir.us.pacio-adi | R4 | LOINCPOLSTReviewAnswerList | LOINC POLST review Answer List | trial-use | 2 | pe | 2025-07 | us | loinc |
hl7.fhir.dk.core | R4 | dk-core-LoincBasicObservation | DK Core LOINC Basic Observations | active | 2025-02 | dk | loinc | ||
hl7.fhir.us.registry-protocols | R4 | RoseDyspneaQ | Rose Dyspnea Questions | active | cic | 2023-11 | us | loinc | |
hl7.fhir.be.patient-monitoring | R4 | holter-event-component-codes | Holter Observation Component Codes | active | 2025-07 | be | loinc | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.202 | Serum Creatinine | active | 2024-02 | us | loinc | ||
hl7.fhir.us.registry-protocols | R4 | SeattleAnginaAs | Seattle Angina Answers | active | cic | 2023-11 | us | loinc | |
hl7.fhir.us.davinci-pas | R4 | X12278DiagnosisInformationType | X12 278 Diagnosis Information Type | trial-use | 3 | fm | 2025-07 | us | loinc |
hl7.fhir.vn.core | R4 | LL2201-3 | LOINC® LL2201-3 - ValueSet về tình trạng hút thuốc | active | 2025-07 | vn | loinc | ||
hl7.fhir.vn.core | R4 | LL3639-3 | LOINC® LL3639-3 - ValueSet về trạng thái lây nhiễm | active | 2025-07 | vn | loinc | ||
hl7.fhir.vn.core | R4 | LL3976-9 | LOINC® LL3976-9 - ValueSet về tần suất hút thuốc | active | 2025-07 | vn | loinc | ||
hl7.fhir.vn.core | R4 | LL940-8 | LOINC® LL940-8 - ValueSet về tình trạng tiêm chủng | active | 2025-07 | vn | loinc | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1235.635 | LP(a) Test_ICD | active | 2025-03 | us | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1260.50 | MSI High | active | 2023-11 | us | sct | ||
ca.on.oh-olis | R4 | olis-RequestTiming | RequestTiming | active | |||||
ca.on.oh-olis | R4 | olis-ReportableTestIndicator | ReportableTestIndicator | active | |||||
hl7.fhir.us.core | R4 | us-core-laboratory-test-codes | US Core Laboratory Test Codes | trial-use | 3 | cgp | 2022-11 | us | loinc |
fhir.cdc.opioid-cds-r4 | R4 | observation-category-laboratory | Observation Category Laboratory | active | 2023-05 | us | |||
hl7.fhir.uv.lab-report | R4 | reportBundleType-uv-lab | Laboratory Report Bundle Types | trial-use | 2 | oo | 2025-01 | uv | fhir |
hl7.fhir.uv.lab-report | R4 | reportType-uv-lab | Laboratory Report Types | trial-use | 2 | oo | 2025-01 | uv | loinc |
hl7.fhir.eu.laboratory | R4 | lab-reportType-eu-lab | Laboratory Report Types | trial-use | 2 | 2025-07 | eu | loinc | |
ch.fhir.ig.ch-vacd | R4 | ch-vacd-laboratory-serology-vs | Laboratory Serology for Immunization | active | 2025-05 | ch | loinc | ||
hl7.fhir.uv.lab-report | R4 | specialty-uv-lab | Laboratory Specialty | trial-use | 2 | oo | 2025-01 | uv | sct |
hl7.fhir.eu.laboratory | R4 | lab-specialty-eu-lab | Laboratory Specialty | trial-use | 2 | 2025-07 | eu | sct | |
hl7.fhir.uv.lab-report | R4 | specimenType-uv-lab | Specimen Types | trial-use | 2 | oo | 2025-01 | uv | sct |
hl7.fhir.eu.laboratory | R4 | lab-specimenType-eu-lab | Specimen Types | trial-use | 2 | 2025-07 | eu | sct | |
hl7.fhir.uv.lab-report | R4 | studyType-uv-lab | Laboratory Study Types | trial-use | 2 | oo | 2025-01 | uv | loinc |
hl7.fhir.eu.laboratory | R4 | lab-studyType-eu-lab | Laboratory Study Types | trial-use | 2 | 2025-07 | eu | loinc | |
hl7.fhir.uv.lab-report | R4 | obsCode-loinc-uv-lab | Laboratory Code: LOINC | trial-use | 2 | oo | 2025-01 | uv | loinc |
hl7.fhir.eu.laboratory | R4 | lab-obsCode-loinc-eu-lab | Laboratory Code: LOINC | trial-use | 2 | 2025-07 | eu | loinc | |
hl7.fhir.uv.lab-report | R4 | obsCode-npu-uv-lab | Laboratory Code: NPU | trial-use | 2 | oo | 2025-01 | uv | |
hl7.fhir.eu.laboratory | R4 | lab-obsCode-npu-eu-lab | Laboratory Code: NPU | trial-use | 2 | 2025-07 | eu | ||
hl7.fhir.uv.lab-report | R4 | obsCode-uv-lab | Laboratory Code | trial-use | 2 | oo | 2025-01 | uv | fhir |
hl7.fhir.eu.laboratory | R4 | lab-obsCode-eu-lab | Laboratory Code | trial-use | 2 | 2025-07 | eu | internal | |
hl7.fhir.us.breastcancer | R3 | oncology-HER2byFISHVSInterpretationTestsVS | BC HER2byFISHVSInterpretationTestsVS ValueSet | draft | 2018-08 | us | loinc | ||
hl7.fhir.us.breastcancer | R3 | oncology-EstrogenReceptorInterpretationTestsVS | BC EstrogenReceptorInterpretationTestsVS ValueSet | draft | 2018-08 | us | loinc | ||
hl7.fhir.us.breastcancer | R3 | oncology-HER2byIHCInterpretationTestsVS | BC HER2byIHCInterpretationTestsVS ValueSet | draft | 2018-08 | us | loinc | ||
hl7.fhir.us.breastcancer | R3 | oncology-ProgesteroneReceptorInterpretationTestsVS | BC ProgesteroneReceptorInterpretationTestsVS ValueSet | draft | 2018-08 | us | loinc | ||
hl7.fhir.uv.lab-report | R4 | technique-uv-lab | Laboratory Techniques | trial-use | 2 | oo | 2025-01 | uv | sct |
hl7.fhir.cz.lab | R4 | cz-lab-technique-vs | Laboratory Techniques | trial-use | 2 | 2025-07 | cz | sct | |
hl7.fhir.eu.laboratory | R4 | lab-technique-eu-lab | Laboratory Techniques | trial-use | 2 | 2025-07 | eu | sct | |
hl7.eu.fhir.idea4rc | R4 | pos-neg-nt-athena-eu-i4rc | Positive-Negative-No Test: Athena | active | 2025-07 | eu | |||
hl7.eu.fhir.idea4rc | R4 | yes-no-unk-athena-eu-i4rc | Yes-No-Unk: Athena | active | 2025-07 | eu | |||
hl7.terminology | R5 | v3-LacrimalPunctaRoute | LacrimalPunctaRoute | active | 2014-03 | uv | tho | ||
ca.on.oh.mha-pds | R4 | Language | Language | active | 2022-08 | ca | tho ietf | ||
hl7.eu.fhir.unicom | R5 | language-ema-vs | EMA SPOR Language | draft | 2025-06 | eu | |||
hl7.terminology | R5 | v3-LaryngealRoute | LaryngealRoute | active | 2014-03 | uv | tho | ||
nictiz.fhir.nl.r4.zib2020 | R4 | 2.16.840.1.113883.2.4.3.11.60.40.2.12.20.2--20200901000000 | LateraliteitCodelijst | active | nl | sct | |||
nictiz.fhir.nl.stu3.zib2017 | R3 | 2.16.840.1.113883.2.4.3.11.60.40.2.13.1.12--20171231000000 | LateraliteitCodelijst | active | nl | sct | |||
hl7.fhir.be.core-clinical | R4 | be-vs-laterality | Laterality | active | 1 | 2021-01 | be | sct | |
ehealthplatform.be.r4.federalprofiles | R4 | be-vs-laterality | Laterality | active | 2021-01 | fhir | |||
hl7.cda.uv.ips | R4 | 2.16.840.1.113883.11.22.57--20171212192725 | Laterality (qualifier) | draft | 2024-08 | uv | sct | ||
ch.fhir.ig.ch-crl | R4 | nkrs-icdo3laterality | NKRS - ICD-O-3 Laterality | active | 2022-02 | ch | internal | ||
hl7.terminology | R5 | v3-LavageRoute | LavageRoute | active | 2014-03 | uv | tho | ||
hl7.org.nz.fhir.ig.formulary | R4B | medicine-classification-code | Legal Medication status | active | 2025-07 | nz | |||
signal.core.r4 | R4 | questionnaire-ccars-legal-status | Questionnaire CCARS Legal Status | draft | 1 | pa | us | ||
hl7.fhir.us.registry-protocols | R4 | LesionSegmentNumber | Lesion Segment Number | active | cic | 2023-11 | us | fhir sct | |
hl7.fhir.us.mcode | R4 | mcode-clark-level-value-vs | Clark Level Value Set | active | cic | 2025-02 | us | sct | |
nictiz.fhir.nl.r4.zib2020 | R4 | 2.16.840.1.113883.2.4.3.11.60.40.2.7.5.1--20200901000000 | LevensovertuigingCodelijst | active | nl | sct tho oid | |||
nictiz.fhir.nl.stu3.zib2017 | R3 | 2.16.840.1.113883.2.4.3.11.60.40.2.7.5.1--20171231000000 | LevensovertuigingCodelijst | active | nl | fhir sct oid | |||
nictiz.fhir.nl.r4.zib2020 | R4 | 2.16.840.1.113883.2.4.3.11.60.40.2.12.12.5--20200901000000 | LichaamsbewegingCodelijst | active | nl | oid | |||
nictiz.fhir.nl.stu3.zib2017 | R3 | 2.16.840.1.113883.2.4.3.11.60.40.2.12.12.5--20171231000000 | LichaamsbewegingCodelijst | active | nl | oid | |||
signal.core.r4 | R4 | questionnaire-answers-status | QuestionnaireResponseStatus | draft | 3 | fhir | 2019-10 | us | fhir |
nictiz.fhir.nl.stu3.zib2017 | R3 | 2.16.840.1.113883.2.4.3.11.60.40.2.10.2.3--20171231000000 | LijnStatusCodelijst | active | nl | fhir oid | |||
hl7.fhir.us.mcode | R4 | mcode-tnm-distant-metastases-staging-type-max-vs | TNM Distant Metastases Staging Type Maximum Value Set | active | 4 | cic | 2025-02 | us | fhir loinc |
hl7.fhir.us.mcode | R4 | mcode-tnm-primary-tumor-staging-type-max-vs | TNM Primary Tumor Staging Type Maximum Value Set | active | 4 | cic | 2025-02 | us | fhir loinc |
hl7.fhir.us.mcode | R4 | mcode-tnm-regional-nodes-staging-type-max-vs | TNM Regional Nodes Staging Type Maximum Value Set | active | 4 | cic | 2025-02 | us | fhir loinc |
hl7.fhir.us.mcode | R4 | mcode-tnm-stage-group-staging-type-max-vs | TNM Stage Group Staging Type Maximum Value Set | active | 4 | cic | 2025-02 | us | fhir loinc |
hl7.fhir.us.mcode | R4 | mcode-condition-status-trend-max-vs | Condition Status Trend Maximum Value Set | active | 3 | cic | 2025-02 | us | fhir sct |
hl7.terminology | R5 | v3-LingualRoute | LingualRoute | active | 2014-03 | uv | tho | ||
hl7.terminology | R5 | v3-RoleClassPersonalRelationship | RoleClassPersonalRelationship | active | 2014-03 | uv | tho | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1235.636 | Lp(a) Test_CPT | active | 2025-03 | us | cpt | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1235.637 | LP(a) Test | active | 2025-03 | us | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1235.634 | Lp(a) Test_LOINC | active | 2025-03 | us | loinc | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1235.633 | Lp(a) Test_SNOMED | active | 2025-03 | us | sct | ||
hl7.fhir.uv.radiation-dose-summary | R4 | isotope-rds-vs | Isotopes Value Set | trial-use | 2 | ii | 2025-05 | uv | dcm |
hl7.fhir.us.resp-net | R4 | resp-net-labtest-covid-codes | resp-net-labtest-covid-codes | draft | 2025-07 | us | cpt loinc | ||
hl7.fhir.us.resp-net | R4 | resp-net-labtest-flu-codes | resp-net-labtest-flu-codes | draft | 2025-07 | us | cpt loinc | ||
hl7.fhir.us.resp-net | R4 | resp-net-labtest-flu-rsv-covid-codes | resp-net-labtest-flu-rsv-covid-codes | draft | 2025-07 | us | cpt loinc | ||
ch.fhir.ig.ch-ems | R4 | IVR-VS-gcs-augenoeffnung | IVR GCS Eye Opening | draft | 2025-07 | ch | internal sct | ||
ch.fhir.ig.ch-ems | R4 | IVR-VS-gcsMotoric | IVR GCS Motoric Response | draft | 2025-07 | ch | internal sct | ||
ch.fhir.ig.ch-ems | R4 | IVR-VS-gcsVerbal | IVR GCS Verbal Response | draft | 2025-07 | ch | internal sct | ||
hl7.fhir.uv.lab-report | R4 | orderCodes-uv-lab | Laboratory Order | trial-use | 2 | oo | 2025-01 | uv | loinc |
hl7.fhir.eu.laboratory | R4 | lab-orderCodes-eu-lab | Laboratory Order | trial-use | 2 | 2025-07 | eu | fhir loinc | |
ch.fhir.ig.ch-ems | R4 | IVR-VS-NACA | IVR NACA | draft | 2025-07 | ch | internal | ||
hl7.fhir.us.resp-net | R4 | resp-net-labtest-rsv-codes | resp-net-labtest-rsv-codes | draft | 2025-07 | us | cpt loinc | ||
hl7.fhir.uv.radiation-dose-summary | R4 | radiopharmaceutical-rds-vs | Radiopharmaceuticals Value Set | trial-use | 2 | ii | 2025-05 | uv | dcm |
hl7.eu.fhir.idea4rc | R4 | drugsAtc-eu-i4rc | Antineoplastic and immunostimulating agents | draft | 2025-07 | eu | atc | ||
hl7.eu.fhir.pcsp | R4 | drugsAtc-eu-pcsp | Antineoplastic and immunostimulating agents | draft | 2025-07 | eu | atc | ||
ch.fhir.ig.ch-ems | R4 | IVR-VS-yesNoUnknown | IVR Yes/No/Unknown | draft | 2025-07 | ch | sct | ||
ch.fhir.ig.ch-ems | R4 | IVR-VS-urgency-adequate | IVR Urgency Adequate | draft | 2025-07 | ch | internal sct | ||
hl7.fhir.us.davinci-crd | R4 | cardType | CRD Card Types Value Set | trial-use | 4 | fm | 2025-07 | us | fhir |
hl7.fhir.us.resp-net | R4 | resp-net-positive-result-codes | resp-net-positive-result-codes | draft | 2025-07 | us | sct |